In-vitro activity of sparfloxacin in comparison with currently available antimicrobials against respiratory tract pathogens
Open Access
- 1 May 1996
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 37 (suppl A) , 1-18
- https://doi.org/10.1093/jac/37.suppl_a.1
Abstract
Bacterial resistance to antimicrobial agents is an ever-increasing problem. The in-vitro activity of sparfloxacin compared with that of currently available antimicrobial agents against pathogens implicated in respiratory tract infections is reviewed. Sparfloxacin is a fluoroquinolone active against both penicillin-susceptible and -resistant strains of Streptococcus pneumoniae. It is also active against many other respiratory tract pathogens and may be a suitable alternative for empirical therapy of community-acquired respiratory tract infections.Keywords
This publication has 0 references indexed in Scilit: